Artificial Intelligence (AI) can be a great tool in diagnosing and management of atopic dermatitis -- a chronic skin conditi ...

With over 1,100 subjects enrolled across 39 clinical study sites, the company is developing and validating the study.

The U.S. Food and Drug Administration has approved Organon's Vtama (tapinarof) 1% cream for an additional indication -- the ...

Andrew Rosenberg, DVM, and Adam Christman, DVM, MBA, talk about shortcomings of treatments approved for canine allergic and ...

A new study from Karolinska Institutet shows that self-guided cognitive behavioral therapy (CBT) online is as effective as ...

The US Food and Drug Administration (FDA) has approved Vtama (tapinarof) cream 1%, an aryl hydrocarbon receptor agonist, for ...

The FDA has approved Vtama® (tapinarof) cream 1% for the topical treatment of atopic dermatitis in patients aged 2 years and older.

For some people, keeping up with eczema treatments can be difficult, but resources are available to help find relief from the ...

HAMPTON, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:CLDX) today announced that the Company has initiated a Phase 2 study of barzolvolimab in atopic dermatitis (AD) and that the study is actively ...

The global hand eczema treatment market is projected to experience robust growth, with a market value of USD 53 million in ...